Rigel Pharmaceuticals Inc. logo Equities research analysts at Jefferies Group increased their price objective on shares of Rigel Pharmaceuticals (NASDAQ:RIGL) from $6.00 to $10.00 in a research note issued to investors on Thursday, ARN reports. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock opened at $4.53 in last session, and closed at $4.75, while the day range of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock is $4.39 – $4.80. The stock showed a positive weekly performance of 36.10%.
GW Pharmaceuticals PLC – ADR (NASDAQ:GWPH) was up and running in Wednesday trading session moving up by roughly 8% at the back of 724, 311 shares exchanging hands. GW Pharmaceuticals PLC – ADR (NASDAQ:GWPH) stock opened at $73.40 in last session, and closed at $77.28 by gaining 6.70%. The 52 week range of $8.46 – $78.42. Company’s market capitalization is $1.15 billion.
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver and intestinal diseases, announced that it will report 2013 full year financial results after the NASDAQ Market closes on Friday, March 14, 2014. Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) stock increased 7.96% and finished the last session at $444.01. The EPS of the stock remained -5.09. Company’s market capitalization is $8.52 billion.
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) announced that its fourth quarter and year end 2013 financial results will be released after the market closes on Tuesday, March 18, 2014. Following the release, Aerie will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the company’s financial results and provide a general business update. Aerie Pharmaceuticals Inc. (NASDAQ:AERI) stock opened the session at $21.00, and closed the session at $22.31. The 52 week range of the Aerie Pharmaceuticals Inc. (NASDAQ:AERI) stock remained $10.25 – $27.15 and the day range was $19.53 – $22.73.